Last Updated:
Sai Life Sciences Ltd’s unlisted shares are trading at Rs 619 per share in the grey market, indicating a premium or GMP of Rs 70 (or 12.75 per cent) over the upper price band.
Sai Life Sciences IPO Allotment Status.
Sai Life Sciences IPO Allotment Status, GMP: The Sai Life Sciences IPO allotment, which closed on Friday with a decent subscription, is set to be finalised in the evening today, Monday. Once allotted, investors will receive the bank debit message. They can also check the allotment status on the websites of BSE and NSE, as well as on registrar Kfin Technologies’ portal. According to market observers, the latest GMP stands at 12.75 per cent, suggesting a positive listing for the Sai Life Sciences IPO on December 18.
The retail portion of the IPO received 1.39 times subscription. Its QIB category got 29.78 times subscription, pushing the overall subscription numbers. The non-institutional category (NII) was subscribed by 4.99 times.
The price band of the IPO was fixed in the range of Rs 522 to Rs 549 apiece. The listing of the IPO will take place on December 18 on both BSE and NSE.
Sai Life Sciences IPO GMP Today
Sai Life Sciences Ltd’s unlisted shares are trading at Rs 619 per share in the grey market, indicating a premium or GMP of Rs 70 (or 12.75 per cent) over the upper price band.
The GMP has witnessed consistent improvement in the past few days, as it had stood at 7.1 per cent on the first day of bidding on December 11.
Sai Life Sciences IPO: A Step-By-Step To Check Allotment Status Online
To check the allotment status for Vishal Mega Mart IPO, follow these steps:
1. Visit the official BSE portal: (https://www.bseindia.com/investors/appli_check.aspx).
2. Select ‘Equity’ under ‘Issue Type’.
3. Choose ‘Sai Life Sciences Ltd’ from the dropdown.
4. Enter your application number or PAN details.
5. Complete the CAPTCHA and click ‘Search’.
Alternatively, allotment details can also be accessed via Kfin Technologies’ portal: (https://ipostatus.kfintech.com/).
Sai Life Sciences IPO: More Details
The IPO has a fresh issue of equity shares worth Rs 950 crore and an offer-for-sale (OFS) of 3.81 crore shares valued at Rs 2,092 crore, by a promoter, investor shareholders and other shareholders.
Its price band was at Rs 522-549 apiece.
Private equity major TPG Capital-backed Sai Life Sciences collected Rs 913 crore from anchor investors, ahead of the IPO opening for public.
Of the overall IPO proceeds, funds to the tune of Rs 600 crore will be used for debt payment and a portion for corporate general purposes.
Hyderabad-based Sai Life Sciences provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities (NCE) to global pharmaceutical innovator companies and biotechnology firms.
Kotak Mahindra Capital Company, IIFL Capital Services, Jefferies India Private Ltd, and Morgan Stanley India Company are the book-running lead managers to the offer.